Science Explorer Back to mapMap
Discussion
Company · Cambridge · United Kingdom

GW Pharmaceuticals (United Kingdom)

gwpharm.comROR OpenAlex
World rank, all time
#17,790
of 34,923
Rank in United Kingdom
#880
of 1,844
Research works
280
▼ 44% vs 2018-21
Citations
21k
73.6 per fractional work
Top-10% rate
10.7%
all institutions 10.0%
vs its own fields
1.21×
1.00× is exactly expected
Open access
37%
world 40%
International
30%
world 18%
GW Pharmaceuticals (United Kingdom)

Which fields of science does GW Pharmaceuticals (United Kingdom) work in?

In 2022-now, 41% of research at GW Pharmaceuticals (United Kingdom) is in Health Sciences, 38% in Life Sciences. Its largest fields are Medicine (39%), Biochemistry, Genetics and Molecular Biology (18%), Agricultural and Biological Sciences (9%). It does 2.0× the world's share of Life Sciences.

Health Sciences: 12 fractional works · 40.9% of its workMedicine: 11 fractional works · 38.7% of its workPhysiology: 2 fractional works · 7.4% of its workPharmacology: 2 fractional works · 6.3% of its workOncology: 1 fractional works · 4.2% of its workNeurology: 1 fractional works · 3.3% of its workGastroenterology: 1 fractional works · 2.5% of its workNephrology: 1 fractional works · 2.3% of its workPsychiatry and Mental health: 1 fractional works · 2.1% of its workPulmonary and Respiratory Medicine: 0 fractional works · 1.7% of its workPathology and Forensic Medicine: 0 fractional works · 1.6% of its workEpidemiology: 0 fractional works · 1.3% of its workGenetics: 0 fractional works · 1.3% of its workSurgery: 0 fractional works · 1.1% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 0.8% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 0.7% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 0.6% of its workDermatology: 0 fractional works · 0.5% of its workImmunology and Allergy: 0 fractional works · 0.3% of its workHematology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.5% of its workHealth Professions: 0 fractional works · 1.2% of its workMedical Laboratory Technology: 0 fractional works · 0.6% of its workPharmacy: 0 fractional works · 0.6% of its workNursing: 0 fractional works · 0.7% of its workNutrition and Dietetics: 0 fractional works · 0.7% of its workDentistry: 0 fractional works · 0.3% of its workPeriodontics: 0 fractional works · 0.3% of its workLife Sciences: 11 fractional works · 37.9% of its workBiochemistry, Genetics and Molecular Biology: 5 fractional works · 18.4% of its workMolecular Biology: 4 fractional works · 12.3% of its workGenetics: 1 fractional works · 3.2% of its workPhysiology: 0 fractional works · 1.8% of its workCell Biology: 0 fractional works · 0.7% of its workBiochemistry: 0 fractional works · 0.4% of its workAgricultural and Biological Sciences: 3 fractional works · 9.0% of its workEcology, Evolution, Behavior and Systematics: 2 fractional works · 7.4% of its workPlant Science: 0 fractional works · 1.2% of its workAquatic Science: 0 fractional works · 0.4% of its workNeuroscience: 2 fractional works · 5.8% of its workCellular and Molecular Neuroscience: 1 fractional works · 2.9% of its workNeurology: 0 fractional works · 1.5% of its workCognitive Neuroscience: 0 fractional works · 0.6% of its workEndocrine and Autonomic Systems: 0 fractional works · 0.6% of its workDevelopmental Neuroscience: 0 fractional works · 0.3% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 3.2% of its workPharmaceutical Science: 1 fractional works · 1.8% of its workPharmacology: 0 fractional works · 0.7% of its workToxicology: 0 fractional works · 0.6% of its workSmaller subfields together: 0 fractional works · 0.0% of its workImmunology and Microbiology: 0 fractional works · 1.5% of its workImmunology: 0 fractional works · 1.5% of its workPhysical Sciences: 4 fractional works · 15.5% of its workChemistry: 2 fractional works · 6.6% of its workOrganic Chemistry: 2 fractional works · 5.4% of its workSpectroscopy: 0 fractional works · 1.1% of its workSmaller subfields together: 0 fractional works · 0.1% of its workComputer Science: 1 fractional works · 3.5% of its workComputational Theory and Mathematics: 0 fractional works · 1.7% of its workArtificial Intelligence: 0 fractional works · 0.9% of its workComputer Vision and Pattern Recognition: 0 fractional works · 0.3% of its workInformation Systems: 0 fractional works · 0.3% of its workSignal Processing: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.0% of its workMaterials Science: 1 fractional works · 3.5% of its workMaterials Chemistry: 1 fractional works · 1.9% of its workBiomaterials: 0 fractional works · 1.1% of its workElectronic, Optical and Magnetic Materials: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.0% of its workEngineering: 0 fractional works · 0.9% of its workArchitecture: 0 fractional works · 0.6% of its workBiomedical Engineering: 0 fractional works · 0.4% of its workPhysics and Astronomy: 0 fractional works · 0.4% of its workAtomic and Molecular Physics, and Optics: 0 fractional works · 0.4% of its workMathematics: 0 fractional works · 0.4% of its workStatistics and Probability: 0 fractional works · 0.4% of its workEarth and Planetary Sciences: 0 fractional works · 0.2% of its workSocial Sciences: 2 fractional works · 5.7% of its workDecision Sciences: 0 fractional works · 1.3% of its workManagement Science and Operations Research: 0 fractional works · 1.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workBusiness, Management and Accounting: 0 fractional works · 1.2% of its workAccounting: 0 fractional works · 0.6% of its workManagement of Technology and Innovation: 0 fractional works · 0.6% of its workSocial Sciences: 0 fractional works · 1.2% of its workGeography, Planning and Development: 0 fractional works · 0.6% of its workSociology and Political Science: 0 fractional works · 0.6% of its workPsychology: 0 fractional works · 1.1% of its workClinical Psychology: 0 fractional works · 1.1% of its workArts and Humanities: 0 fractional works · 0.6% of its workHistory: 0 fractional works · 0.6% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.5% of its workEconomics and Econometrics: 0 fractional works · 0.5% of its workALL ITS WORKGWPharmaceuticals…29fractional works, 2022-now
Life Sciences38%Physical Sciences16%Health Sciences41%Social Sciences6%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 22 fields, with their numbers
    1. Medicine1138.7%
    2. Health Professions01.2%
    3. Nursing00.7%
    4. Dentistry00.3%
    1. Biochemistry, Genetics and Molecular Biology518.4%
    2. Agricultural and Biological Sciences39.0%
    3. Neuroscience25.8%
    4. Pharmacology, Toxicology and Pharmaceutics13.2%
    5. Immunology and Microbiology01.5%
    1. Chemistry26.6%
    2. Computer Science13.5%
    3. Materials Science13.5%
    4. Engineering00.9%
    5. Physics and Astronomy00.4%
    6. Mathematics00.4%
    7. Earth and Planetary Sciences00.2%
    1. Decision Sciences01.3%
    2. Business, Management and Accounting01.2%
    3. Social Sciences01.2%
    4. Psychology01.1%
    5. Arts and Humanities00.6%
    6. Economics, Econometrics and Finance00.5%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 1.88× its world share, 3 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.45× its world share, 5 worksBiochemistry, Geneti…Immunology and Microbiology: 1.55× its world share, 0 worksImmunology and Micro…Neuroscience: 3.61× its world share, 2 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 8.90× its world share, 1 worksPharmacology, Toxico…Chemistry: 4.21× its world share, 2 worksChemistryComputer Science: 0.45× its world share, 1 worksComputer ScienceEarth and Planetary Sciences: 0.12× its world share, 0 worksEarth and Planetary …Engineering: 0.06× its world share, 0 worksEngineeringMaterials Science: 1.00× its world share, 1 worksMaterials ScienceMathematics: 0.30× its world share, 0 worksMathematicsPhysics and Astronomy: 0.17× its world share, 0 worksPhysics and AstronomyDentistry: 0.60× its world share, 0 worksDentistryHealth Professions: 0.44× its world share, 0 worksHealth ProfessionsMedicine: 2.01× its world share, 11 worksMedicineNursing: 1.46× its world share, 0 worksNursingArts and Humanities: 0.20× its world share, 0 worksArts and HumanitiesBusiness, Management and Accounting: 0.36× its world share, 0 worksBusiness, Management…Decision Sciences: 1.34× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 0.22× its world share, 0 worksEconomics, Econometr…Psychology: 0.34× its world share, 0 worksPsychologySocial Sciences: 0.09× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 8.9×. Every wedge is a field page.

All 22 fields, with their numbers
  1. Pharmacology, Toxicology and Pharmaceutics8.90×1 works
  2. Chemistry4.21×2 works
  3. Neuroscience3.61×2 works
  4. Biochemistry, Genetics and Molecular Biology3.45×5 works
  5. Medicine2.01×11 works
  6. Agricultural and Biological Sciences1.88×3 works
  7. Immunology and Microbiology1.55×0 works
  8. Nursing1.46×0 works
  9. Decision Sciences1.34×0 works
  10. Materials Science1.00×1 works
  11. Dentistry0.60×0 works
  12. Computer Science0.45×1 works
  13. Health Professions0.44×0 works
  14. Business, Management and Accounting0.36×0 works
  15. Psychology0.34×0 works
  16. Mathematics0.30×0 works
  17. Economics, Econometrics and Finance0.22×0 works
  18. Arts and Humanities0.20×0 works
  19. Physics and Astronomy0.17×0 works
  20. Earth and Planetary Sciences0.12×0 works
  21. Social Sciences0.09×0 works
  22. Engineering0.06×0 works

Who are the top researchers at GW Pharmaceuticals (United Kingdom)?

Ranked on the quality score, Graeme C.M. Smith, Niall M.B. Martin and Stephen Wright lead among researchers whose main affiliation is GW Pharmaceuticals (United Kingdom).

  1. 1 Graeme C.M. Smith United Kingdom · #60,208 worldwide 21k citations · 186 works
  2. 2 Niall M.B. Martin United Kingdom · #189,867 worldwide 14k citations · 96 works
  3. 3 Stephen Wright United Kingdom · #202,496 worldwide 7.8k citations · 88 works
  4. 4 Daniel Checketts United Kingdom · #345,828 worldwide 2.9k citations · 37 works
  5. 5 Colin G. Stott United Kingdom · #397,674 worldwide 3.2k citations · 35 works
  6. 6 Marnie Duncan United Kingdom · #460,951 worldwide 4k citations · 27 works
  7. 7 Stuart H. Ratcliffe United Kingdom · #480,390 worldwide 2.5k citations · 23 works
  8. 8 Gilmour Morrison United Kingdom · #593,151 worldwide 1.6k citations · 18 works
  9. 9 Marta Żołnowska United Kingdom · #765,497 worldwide 1.7k citations · 14 works
  10. 10 Geoffrey W. Guy United Kingdom · #805,744 worldwide 3.3k citations · 54 works
All ranked researchers at GW Pharmaceuticals (United Kingdom)

What are the most cited papers from GW Pharmaceuticals (United Kingdom)?

The most cited paper from GW Pharmaceuticals (United Kingdom) is "Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy" (Hannah Farmer, Nuala McCabe, Christopher J. Lord et al., 2005), with 6,785 citations. Next come "Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers" (3,663) and "Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome" (1,708).

Most cited papers
#PaperReleasedCitations
1 Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy Hannah Farmer, Nuala McCabe, Christopher J. Lord et al. · Nature Apr 2005 6,785
2 Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers Peter C.C. Fong, David S. Boss, Timothy Anthony Yap et al. · New England Journal of Medicine Open access 24 Jun 2009 3,663
3 Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome Orrin Devinsky, Judith Helen Cross, Linda Laux et al. · New England Journal of Medicine Open access 24 May 2017 1,708
4 Taming THC: potential cannabis synergy and phytocannabinoid‐terpenoid entourage effects Ethan B. Russo · British Journal of Pharmacology Open access 12 Jul 2011 1,541
5 Deficiency in the Repair of DNA Damage by Homologous Recombination and Sensitivity to Poly(ADP-Ribose) Polymerase Inhibition Nuala McCabe, Nicholas C. Turner, Christopher J. Lord et al. · Cancer Research 15 Aug 2006 1,321
All 59 most cited papers, with filters and sorting

Which keywords describe research at GW Pharmaceuticals (United Kingdom)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Neurological Disorders, Cancer Therapy, Cannabinoid Receptors, Endocannabinoid System, Phylogeny, Epilepsy, Diagnostic Criteria and Taxonomy.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 17 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 17 words, with their numbers
  1. Neurological Disorders4▲ 23×9 topics
  2. Cancer Therapy2▲ 13×11 topics
  3. Inflammation2▲ 3.1×10 topics
  4. Cannabinoid Receptors2▲ 191×1 topic
  5. Endocannabinoid System2▲ 191×1 topic
  6. Phylogeny2▲ 37×5 topics
  7. Epilepsy2▲ 48×3 topics
  8. Diagnostic Criteria1▲ 21×5 topics
  9. Taxonomy1▲ 34×4 topics
  10. Biodiversity1▲ 6.1×3 topics
  11. DNA Barcoding1▲ 27×3 topics
  12. Genetics1▲ 6.6×6 topics
  13. Machine Learning1▲ 1.36×5 topics
  14. Cancer1▲ 3.2×5 topics
  15. Cognitive Impairment1▲ 16×2 topics
  16. Invasive Species1▲ 8.7×3 topics
  17. Evolution1▲ 13×2 topics

Which research topics does GW Pharmaceuticals (United Kingdom) publish most on?

By volume in 2022-now: Cannabis and Cannabinoid Research, Tuberous Sclerosis Complex Research, Lepidoptera: Biology and Taxonomy and Renal Diseases and Glomerulopathies.

Cannabis and Cannabinoid…2Cannabis and Cannabinoid Research: 2 fractional worksTuberous Sclerosis Complex Research: 1 fractional worksLepidoptera: Biology and Taxonomy: 1 fractional worksRenal Diseases and Glomerulopathies: 1 fractional worksNeuroscience and Neuropharmacology Research: 1 fractional worksComputational Drug Discovery Methods: 0 fractional worksAmyotrophic Lateral Scle…0Amyotrophic Lateral Sclerosis Research: 0 fractional worksCalcium signaling and nucleotide metabolism: 0 fractional worksGastrointestinal motility and disorders: 0 fractional worksCancer-related Molecular…0Cancer-related Molecular Pathways: 0 fractional works
PharmacologyPhysiologyGeneticsNephrology5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Cannabis and Cannabinoid Research Pharmacology 2 works
  2. 2 Tuberous Sclerosis Complex Research Physiology 1 works
  3. 3 Lepidoptera: Biology and Taxonomy Genetics 1 works
  4. 4 Renal Diseases and Glomerulopathies Nephrology 1 works
  5. 5 Neuroscience and Neuropharmacology Research Cellular and Molecular Neuroscience 1 works
  6. 6 Computational Drug Discovery Methods Computational Theory and Mathematics 0 works
  7. 7 Amyotrophic Lateral Sclerosis Research Neurology 0 works
  8. 8 Calcium signaling and nucleotide metabolism Physiology 0 works
  9. 9 Gastrointestinal motility and disorders Gastroenterology 0 works
  10. 10 Cancer-related Molecular Pathways Oncology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available36.6%not open63.4%

World: 40% of research is openly available.

with international co-authors30.1%domestic only69.9%

World: 18% is written across borders.

How has GW Pharmaceuticals (United Kingdom)'s research output changed?

Output in 2022-2025 was 44% lower than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is GW Pharmaceuticals (United Kingdom) as a percentage of every work published that year, 0.00012% in 2024.

still counting0.00050%0.0010%0.0015%GW Pharmaceuticals (United Kingdom)0.00017% in 202519801990200020102020

Fractional works of GW Pharmaceuticals (United Kingdom) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Cambridge

All research institutions in Cambridge

Share GW Pharmaceuticals (United Kingdom)'s ranking

GW Pharmaceuticals (United Kingdom) on Science Explorer

A card with GW Pharmaceuticals (United Kingdom)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about GW Pharmaceuticals (United Kingdom). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.